Quarterly report [Sections 13 or 15(d)]

Note 6 - Related Party Transactions

v3.26.3
Note 6 - Related Party Transactions
 9 Months Ended
Sep. 30, 2026
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

Note 6 – Related Party Transactions

 

There were no related party transactions outside of the ordinary course of business for the three and nine months ended September 30, 2026. As of September 30, 2026 and 2025, Tactic Pharma, the Company’s initial investor, beneficially owned 0% and 4.1% of Monopar’s common stock, respectively, and during the three and nine months ended September 30, 2025, there was one transaction between Tactic Pharma and Monopar, related to the Share Purchase Agreement on September 24, 2025 (See Note 4). On January 28, 2026, Tactic Pharma conducted a liquidating, pro rata distribution of the Company’s common stock to its members. The Company considers the following individual as a related party: Chandler D. Robinson is a Company Co-Founder, Chief Executive Officer, common stockholder, non-controlling Managing Member of Tactic Pharma, former Manager of the predecessor LLC, Manager of CDR Pharma, LLC and Board member of Monopar as a C Corporation as of September 30, 2025.